Biography
Dr Adil Daud is a nationally recognized expert in early phase drug development in skin cancer and solid tumors. He earned a medical degree at the Government Medical College in Nagpur, India. He completed an internship and residency in internal medicine at Indiana University Medical Center, followed by a fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center.
Prior to joining UCSF Medical Center, he was Associate Professor and Director of the Affiliate Network at the Moffitt Cancer Center in Tampa, Fla. for seven years. Daud has won numerous awards, including the American Society for Clinical Oncology's Young Investigator award and Castle Connolly's Best Doctors in America award. He is an professor of medicine at UCSF.
Education
St. Francis De Sales College, Nagpur, India, 1980, HSC Diploma in General Science
Government Medical College, Nagpur, India, 1986, MBBS degree in Medicine
Internship and Residency in Internal Medicine, Indiana University Medical Center, Indianapolis, IN, 1994-1997
Fellowship in Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, 1997-2000
Postdoctoral Fellow, Laboratory of F. Merlin Bumpus, PhD and Ahsan Husain, PhD, Cleveland Clinic Foundation, Cleveland, OH, 1987-1990
Research Assistant Staff, Laboratory of Loren Field, PhD, Krannert Institute of Cardiology, Indiana University Medical Center, Indianapolis, IN, 1990-1994
Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Clinical Expertise
Basal Cell Carcinoma
Squamous Cell Carcinoma
Skin Cancer in Immunosuppressed Patients
Melanoma
Merkel Cell Carcinoma
Kaposi's sarcoma
Skin adnexal tumors
Skin sarcomas
Program Affiliations
Department of Medicine, Division of Hematology Oncology
UCSF Melanoma Center
Member, UCSF Helen Diller Family Comprehensive Cancer Center
Research Narrative
Dr. Daud is Director of Melanoma Research at the UCSF Helen Diller Family Comprehensive Cancer Center. The programs goal is to better understand the biology of melanoma and develop new treatments for the disease. Daud has led numerous clinical trials that have expanded the use of targeted therapy for melanoma.
Research Interests
BRAF Mutation-Positive Metastatic Melanoma
Phase I Investigational Agents for Solid Tumors
Targeted Therapy in Melanoma